Gut inflammation alters bacteria, triggering food sensitivities in IBD patients

Two-thirds of people living with inflammatory bowel disease report that certain foods make them sick. Dairy. Wheat. Fiber. The list varies from person to person, but the pattern is consistent enough that many IBD patients—those with Crohn's disease or ulcerative colitis—reshape their entire diets around these suspected triggers, hoping to avoid the cramping, inflammation, and flare-ups that define their condition. Yet here is the puzzle: many of these foods caused no problems before the disease took hold. Something changes. Until now, no one has fully understood what.

A study forthcoming in Gastroenterology offers a mechanism. Researchers at McMaster University Medical Centre, led by Alberto Caminero and colleagues including Bruna Barbosa, Neeraj Narula, and Premysl Bercik, found that gut inflammation doesn't just damage the intestinal lining—it fundamentally alters the bacteria living there, and that alteration is what triggers the immune reactions patients experience. The foods themselves are not the culprit. The bacteria that normally process those foods are.

The gut microbiota—the trillions of bacteria colonizing the intestines—perform a metabolic function the human body cannot accomplish alone. They break down food components that our own enzymes cannot digest. When IBD flares, inflammation depletes the specific bacterial species responsible for processing common trigger foods. The researchers demonstrated this in two mouse models of colitis. After inflammation, exposure to dairy or gluten triggered an allergic-type immune response in the colon. When those foods were reintroduced later, the animals showed heightened gut sensitivity and worsening colitis symptoms. The mechanism was clear: the bacteria that normally neutralize these foods had vanished.

The evidence went deeper. When researchers transferred gut bacteria from inflamed mice into germ-free mice—animals with no microbiota of their own—those recipient mice became prone to sensitization to the same foods. Conversely, restoring the missing bacteria reduced these effects. The disruption of the microbiota, not the foods, was driving the immune reaction. The pattern held in human patients. Among IBD sufferers who reported food intolerances, researchers found both a reduced capacity to break down common trigger foods and lower levels of the bacteria responsible for that breakdown.

This finding reframes how clinicians and patients might approach food management in IBD. For decades, the standard advice has been dietary restriction—avoid the foods that seem to cause problems. But if the problem is not the food but the absence of the bacteria that process it, then the solution may lie not in restriction but in restoration. Caminero noted that the microbiome functions as a metabolic organ, and inflammation impairs that function. The implication is that microbiome-based therapies could restore bacterial digestive capacity, offering IBD patients a path beyond the constant negotiation with their own diet.

The researchers acknowledge that microbiota disruption is one piece of a larger puzzle. Genetics, infections, and stress all contribute to IBD and food sensitivities, and all require further investigation. But this study identifies a specific, testable mechanism—one that opens new possibilities for treatment. Rather than asking patients to eliminate foods, future therapies might focus on rebuilding the bacterial communities that allow those foods to be safely digested. For the millions of IBD patients currently managing their condition through dietary restriction, that shift could mean the difference between a life constrained by fear of food and one where eating is simply eating again.